Cardlytics (CDLX) IPO Opens 7% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil prices, Treasury yields remain elevated
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
Cardlytics (CDLX) IPO Price at $13
February 9, 2018 6:31 AM ESTCardlytics, Inc., (NASDAQ: CDLX) announced the pricing of its initial public offering of 5,400,000 shares of common stock at a price to the public of $13.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Cardlytics. In addition, Cardlytics has granted the underwriters a 30-day... More
